08/07/2020

UK GOV Update: Procuring Medical Equipment

The COVID-19 outbreak has led to an increase in demand for Personal Protective Equipment (PPE), including equipment manufactured in China. 
 
It is important that buyers consider risks and undertake due diligence before entering into any contractual arrangements or transferring funds to purchase PPE.
 
This note aims to inform UK companies and organisations of the main processes involved in procuring PPE from China as they are currently understood by the British Embassy, Beijing, and provide guidance to any companies who have run into difficulties. This includes guidance on new regulatory measures issued by the Chinese government to ensure the quality of PPE and other healthcare supplies for export.
 
Bribery and corruption
 
Before attempting any procurement, we advise strongly that business read our guidance in Understanding and Managing the risks.
 
Establishing that a manufacturer can export
 
In order to export to the UK from China, the Chinese authorities require all Chinese manufacturers to register with the Chinese regulator, the National Medical Products Administration (NMPA), and be CE marked.
 
If the Chinese manufacturer has not registered with the NMPA or has a CE mark, they can apply to be put on a ‘whitelist’ that facilitates clearance by Chinese customs.
 
Depending on the type of PPE equipment being procured, Chinese authorities may also require various documentation and certification in order to release products for export. It is recommended that buyers check the latest customs guidance before purchase, and verify with suppliers and intermediaries (including customs agents) that all documentation is available.
 
In addition, if you are procuring on behalf of the UK NHS, you should check with the Department for Health and Social Care (DHSC) or the relevant procuring agency to make sure the product’s specification meets NHS technical requirements.
 
Importers should also ensure compliance with all duty and other requirements at the UK border.
 
Please click here to read the full details.

 

08/07/2020